Inhibition of the EGF receptor and ERK1/2 signaling pathways rescues the human epidermoid carcinoma A431 cells from IFNγ-induced apoptosis

Cell Cycle

Volumn 10, Issue 13, 2011, Pages 2197-2205

  Burova, Elena B ^a   Smirnova, Irina S ^a   Gonchar, Ilya V ^a   Shatrova, Alla N ^a   Nikolsky, Nikolay N ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

A431 cells; Apoptosis; Caspase 3; Cell cycle; EGFR; ERK1 2; IFN

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; RECOMBINANT GAMMA INTERFERON;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 79959949690     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.13.16055     Document Type: Article

References (55)

1. 1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ 1996; 7:289-300.
2. Kano A, Haruyama T, Akaike T, Watanabe Y. IRF-1 is an essential mediator in IFNgamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem Biophys Res Commun 1999; 257:672-7; DOI: 10.1006/bbrc.1999.0276.
3. McCullough CT, Tura BJ, Harrison DJ. c-Myc partially mediates IFNgamma-induced apoptosis in the primary hepatocyte. Int J Exp Pathol 2007; 88:129-36; DOI: 10.1111/j.1365-2613.2006.00521.x.
4. Mebratu YA, Dickey BF, Evans C, Tesfaigzi Y. The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgammainduced cell death. J Cell Biol 2008; 183:429-39; DOI: 10.1083/jcb.200801186.
5. Bernstein W, Zou ZQ, Black R, Pirollo KF, Chang EH. Association of interferon-gamma induced growth inhibition and modulation of epidermal growth factor receptor gene expression in squamous cell carcinoma cell lines. J Biol Regul Homeost Agents 1988; 2:186-92. (Pubitemid 19166926)
6. Lombardero J, Perez R, Skoog L. Synergistic inhibitory effect of gamma-interferon and EGF on A431 cells. Anticancer Res 1992; 12:201-4.
7. Lizard G, Chignol MC, Chardonnet Y, Schmitt D. Differences of reactivity to interferon gamma in HeLa and CaSki cells: a combined immunocytochemical and flow-cytometric study. J Cancer Res Clin Oncol 1996; 122:223-30; DOI: 10.1007/BF01209650.
8. Buard A, Vivo C, Monnet I, Boutin C, Pilatte Y, Jaurand MC. Human malignant mesothelioma cell growth: activation of Janus kinase 2 and signal transducer and activator of transcription 1 for inhibition by interferon*2. Cancer Res 1998; 58:840-7. (Pubitemid 28099501)
9. WAF1/CIP1. Oncogene 1998; 17:2973-9; DOI: 10.1038/sj.onc.1202217.
10. Gooch JL, Herrera RE, Yee D. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Cell Growth Differ 2000; 11:335-42; Pubmed.
11. Seymour L, Bezwoda EC. Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biological effects of two growth modulators. Br J Cancer 1993; 68:352-6; DOI: 10.1038/bjc.1993.339.
12. Platanias LC. Interferons: laboratory to clinic investigations. Curr Opin Oncol 1995; 7:560-5; DOI: 10.1097/00001622-199511000-00015.
13. Merchant MS, Yang X, Melchionda F, Romero M, Klein R, Thiele CJ, et al. Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma. Cancer Res 2004; 64:8349-56; DOI: 10.1158/0008-5472.CAN-04-1705.
14. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415-21; DOI: 10.1126/science.8197455.
15. Bach EA, Aguet M, Schreiber RD. The IFNgamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997; 15:563-91; DOI: 10.1146/annurev.immunol.15.1.563.
16. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163-89; DOI: 10.1189/jlb.0603252.
17. ras-independent. J Biol Chem 1998; 273:3021-6; DOI: 10.1074/jbc.273.5.3021.
18. Takaoka A, Tanaka N, Mitani Y, Miyazaki T, Fujii H, Sato M, et al. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFNgamma, but not IFNalpha, signaling. EMBO J 1999; 18:2480-8; DOI: 10.1093/emboj/18.9.2480.
19. Nguyen VA, Chen J, Hong F, Ishac E, Gao B. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism. Biochem J 2000; 349:427-34; DOI: 10.1042/0264-6021: 3490427.
20. WAF1/CIP1 mediated by STAT1. Science 1996; 272:719-22; DOI: 10.1126/science.272.5262.719.
21. Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells. Oncogene 1997; 14:2111-22; DOI: 10.1038/sj.onc.1201055.
22. Kortylewski M, Komyod W, Kauffmann ME, Bosserhoff A, Heinrich PC, Behrmann I. Interferongamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals. J Invest Dermatol 2004; 122:414-22; DOI: 10.1046/j.0022-202X.2004.22237.x.
23. Supriya P, Joshi CV, Ajitkumar P. IFN-gamma inhibits growth of WISH cells in a cell cycle phase-specific manner. J Interferon Cytokine Res 1998; 18:215-7; DOI: 10.1089/jir.1998.18.215.
24. Vashistha S, Patil S, Joshi C, Ajitkumar P. Determination of growth inhibitory action point of interferon gamma on WISH cells in cell cycle progression and the window of responsiveness of the cells to the interferon. Cytokine 2007; 37:108-18; DOI: 10.1016/j.cyto.2007.02.013.
25. Sato T, Selleri C, Young NS, Maciejewski JP. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. Blood 1997; 90:4749-58. (Pubitemid 28007188)
26. Tomita Y, Bilim V, Hara N, Kasahara T, Takahashi K. Role of IRF-1 and caspase-7 in IFN-gamma enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells. Int J Cancer 2003; 104:400-8; DOI: 10.1002/ijc.10956.
27. Horiuchi M, Itoh A, Pleasure D, Itoh T. MEK-ERK signaling is involved in interferon-gamma-induced death of oligodendroglial progenitor cells. J Biol Chem 2006; 281:20095-106; DOI: 10.1074/jbc.M603179200.
28. Xu X, Fu XY, Plate J, Chong AS. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for upregulation of Fas and FasL expression. Cancer Res 1998; 58:2832-7. (Pubitemid 28311915)
29. Dimco G, Knight RA, Latchman DS, Stephanou A. STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest. Cell Cycle 2010; 9:4638-49; DOI: 10.4161/cc.9.23.13955.
30. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997; 17:5328-37. (Pubitemid 27357631)
31. Ruiz-Ruiz C, Muñoz-Pinedo C, López-Rivas A. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. Cancer Res 2000; 60:5673-80; Pubmed.
32. Sironi JJ, Ouchi T. STAT1-induced apoptosis is mediated by caspases 2, 3 and 7. J Biol Chem 2004; 279:4066-74; DOI: 10.1074/jbc.M307774200.
33. Ning Y, Riggins RB, Mulla JE, Chung H, Zwart A, Clarke R. IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NFkappaB, BCL2 family members and signaling to caspase-dependent apoptosis. Mol Cancer Ther 2010; 9:1274-85; DOI: 10.1158/1535-7163.MCT-09-1169.
34. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003; 284:31-53; DOI: 10.1016/S0014-4827(02)00098-8.
35. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000; 103:211-25; DOI: 10.1016/S0092-8674(00)00114-8.
36. Carpenter G. Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J Cell Biol 1999; 146:697-702; DOI: 10.1083/jcb.146.4.697.
37. Burova E, Vassilenko K, Dorosh V, Gonchar I, Nikolsky N. Interferon gamma-dependent transactivation of epidermal growth factor receptor. FEBS Lett 2007; 581:1475-80; DOI: 10.1016/j.febslet.2007.03.002.
38. Stork PJ. ERK signaling: duration, duration, duration. Cell Cycle 2002; 1:315-7; DOI: 10.4161/cc.1.5.145.
39. Zhuang S, Schnellmann RG. A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 2006; 319:991-7; DOI: 10.1124/jpet.106.107367.
40. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267:1782-8; DOI: 10.1126/science.7892601.
41. Friday BB, Adjei AA. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res 2008; 14:342-6; DOI: 10.1158/1078-0432.CCR-07-4790.
42. Chang EH, Ridge J, Black R, Zou ZQ, Masnyk T, Noguchi P, et al. Interferon-gamma induces altered oncogene expression and terminal differentiation in A431 cells. Proc Soc Exp Biol Med 1987; 186:319-26; Pubmed.
43. Ridge J, Muller J, Noguchi P, Chang EH. Dynamics of differentiation in human epidermoid squamous carcinoma cells (A431) with continuous, long-term gamma-IFN treatment. In Vitro Cell Dev Biol 1991; 27A:417-24; DOI: 10.1007/BF02630962.
44. Blank M, Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle 2007; 6:686-95; DOI: 10.4161/cc.6.6.3990.
45. Wolf BB, Green DR. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 1999; 274:20049-52; DOI: 10.1074/jbc.274.29. 20049.
46. Slee EA, Adrain C, Martin SJ. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 2001; 276:7320-6; DOI: 10.1074/jbc.M008363200.
47. Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T. Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 1996; 229:21-6; DOI: 10.1006/bbrc.1996.1752.
48. Busse D, Doughty RS, Ramsey TT, Russell WE, Price JO, Flanagan WM, et al. Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires upregulation of p27(KIP1) independent of MAPK activity. J Biol Chem 2000; 275:6987-95; DOI: 10.1074/jbc.275.10.6987.
49. Satoh T, Nakatsuka D, Watanabe Y, Nagata I, Kikuchi H, Namura S. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci Lett 2000; 288:163-6; DOI: 10.1016/S0304-3940(00)01229-5.
50. Lai JM, Wu S, Huang DY, Chang ZF. Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21(Cip1/Waf1) in phorbol 12-myristate-13- acetate-induced apoptotic cells. Mol Cell Biol 2002; 22:7581-92; DOI: 10.1128/MCB.22.21.7581-92.2002.
51. 2-induced cell death. Eur J Pharmacol 2004; 483:163-73; DOI: 10.1016/j.ejphar.2003.10.032.
52. Smirnova IS, Chang S, Forsthuber TG. Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro. Cell Immunol 2010; 261:29-36; DOI: 10.1016/j.cellimm.2009.10.008.
53. Gulli LF, Palmer KC, Chen YQ, Reddy KB. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ 1996; 7:173-8. (Pubitemid 26049825)
54. Van de Vijver MJ, Kumar R, Mendelsohn J. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J Biol Chem 1991; 266:7503-8. (Pubitemid 21906393)
55. Uribe JM, McCole DF, Barrett KE. Interferon-γ activates EGF receptor and increases TGFα in T84 cells: implications for chloride secretion. Am J Physiol Gastrointest Liver Physiol 2002; 283:923-31.